Walnut Creek, California Clinical Trials

A listing of Walnut Creek, California clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 59 clinical trials
Dose-finding Study to Evaluate Efficacy and Safety of LOU064 in Patients With CSU Inadequately Controlled by H1-antihistamines

This is a multicenter, randomized, double-blind and placebo-controlled phase 2b dose-finding study to assess the efficacy and safety of LOU064 in adults chronic spontaneous urticaria (CSU) patients inadequately controlled by H1-antihistamines

antihistamines
urticaria
treatment guidelines
Novartis Investigative Site
 (2.2 away) Contact site
  • 82 views
  • 20 Nov, 2020
  • +83 other locations
Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors Lymphomas or Multiple Myeloma (The MATCH Screening Trial)

This phase II MATCH trial studies how well treatment that is directed by genetic testing works in patients with solid tumors or lymphomas that have progressed following at least one line of standard treatment or for which no agreed upon treatment approach exists. Genetic tests look at the unique genetic …

afatinib
primary brain tumors
fgfr inhibitor
binimetinib
sunitinib malate
Kaiser Permanente-Walnut Creek
 (0.7 away) Contact site
  • 6087 views
  • 25 Nov, 2020
  • +967 other locations
Targeted Therapy Directed by Genetic Testing in Treating Pediatric Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphomas or Histiocytic Disorders (The Pediatric MATCH Screening Trial)

This Pediatric MATCH screening and multi-sub-study phase II trial studies how well treatment that is directed by genetic testing works in pediatric patients with solid tumors, non-Hodgkin lymphomas, or histiocytic disorders that have progressed following at least one line of standard systemic therapy and/or for which no standard treatment exists …

vemurafenib
pleural effusions
cancer
hematopoietic growth factors
tumor markers
Kaiser Permanente-Oakland
 (9.6 away) Contact site
  • 990 views
  • 28 Nov, 2020
  • +111 other locations
Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

This phase II trial studies nivolumab and ipilimumab in treating patients with rare tumors. Immunotherapy with monoclonal antibodies, such as nivolumab and ipilimumab, may help the body's immune system attack the cancer, and may interfere with the ability of tumor cells to grow and spread. This trial enrolls participants for …

adenocarcinoma
octreotide
pd-l1
squamous cell carcinoma of the head and neck
cancer
Epic Care Cyberknife Center
 (0.7 away) Contact site
  • 5957 views
  • 27 Nov, 2020
  • +770 other locations
Reduced Craniospinal Radiation Therapy and Chemotherapy in Treating Younger Patients With Newly Diagnosed WNT-Driven Medulloblastoma

This phase II trial studies how well reduced doses of radiation therapy to the brain and spine (craniospinal) and chemotherapy work in treating patients with newly diagnosed type of brain tumor called WNT)/Wingless (WNT)-driven medulloblastoma. Recent studies using chemotherapy and radiation therapy have been shown to be effective in treating …

brain tumor
lomustine
cancer
immunohistochemistry
cyclophosphamide
Kaiser Permanente-Oakland
 (9.6 away) Contact site
  • 119 views
  • 27 Nov, 2020
  • +130 other locations
A Study of LY3209590 in Participants With Type 1 Diabetes

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 1 diabetes.

body mass index
insulin
glycosylated hemoglobin
hemoglobin a1c
type 1 diabetes mellitus
John Muir Physician Network Clinical Research Center
 (8.8 away) Contact site
  • 523 views
  • 25 Nov, 2020
  • +85 other locations
A Phase 2 Study of LY3209590 in Participants With Type 2 Diabetes Mellitus

The reason for this study is to see if the study drug LY3209590 is safe and effective in participants with type 2 diabetes.

metformin
insulin
hemoglobin a1c
drug test
type 2 diabetes mellitus
Diablo Clinical Research
 (4.7 away) Contact site
  • 352 views
  • 25 Nov, 2020
  • +126 other locations
A 16 Week Study to Evaluate the Efficacy and Safety of PF-06882961 in Adults With Type 2 Diabetes Mellitus

This multicenter, randomized, double-blind, placebo controlled, parallel group study is being conducted to provide data on efficacy, safety, tolerability and pharmacokinetics (PK) of multiple dose levels of PF-06882961 in adults with type 2 diabetes mellitus (T2DM) inadequately controlled on metformin and/or diet and exercise. In addition, the study is intended …

metformin
Diablo Clinical Research Incorporated
 (4.7 away) Contact site
  • 134 views
  • 25 Nov, 2020
  • +90 other locations
Olaparib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With Defects in DNA Damage Repair Genes (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well olaparib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders with defects in deoxyribonucleic acid (DNA) damage repair genes that have spread to other places in the body (advanced) and have come back (relapsed) or do not respond …

pleural effusions
niraparib
cancer
hematopoietic growth factors
tumor markers
Kaiser Permanente-Oakland
 (9.6 away) Contact site
  • 199 views
  • 28 Nov, 2020
  • +71 other locations
Erdafitinib in Treating Patients With Relapsed or Refractory Advanced Solid Tumors Non-Hodgkin Lymphoma or Histiocytic Disorders With FGFR Mutations (A Pediatric MATCH Treatment Trial)

This phase II Pediatric MATCH trial studies how well erdafitinib works in treating patients with solid tumors, non-Hodgkin lymphoma, or histiocytic disorders that have spread to other places in the body and have come back or do not respond to treatment with FGFR mutations. Erdafitinib may stop the growth of …

fgfr inhibitor
pleural effusions
cancer
hematopoietic growth factors
fgfr inhibitor azd4547
Kaiser Permanente-Oakland
 (9.6 away) Contact site
  • 261 views
  • 28 Nov, 2020
  • +78 other locations